Rosuvastatin |
Rosuvastatin Products |
| Nicostatin, rosuvastatin, ezetimibe to debut soon. (Excellent Safety Profiles).: An article from: Internal Medicine News Bruce Jancin International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Rosuvastatin reduces non-HDL levels: statins compared.(Cardiovascular Medicine): An article from: Internal Medicine News Bruce Jancin International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Nicostatin, rosuvastatin, and ezetimibe will debut soon. (Excellent Safety Profiles).(Brief Article): An article from: Family Practice News Bruce Jancin International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Rosuvastatin approved for hypercholesterolemia: most potent statin to date.(News)(Crestor from AstraZeneca PLC): An article from: Family Practice News Elizabeth Mechcatie International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| FDA okays rosuvastatin for hypercholesterolemia: most potent statin to date.(Rx): An article from: Internal Medicine News Elizabeth Mechcatie International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Rosuvastatin linked to excess adverse events: use is associated with reports of rhabdomyolysis, proteinuria, nephropathy, and renal failure.(Cardiovascular ... An article from: Family Practice News Mitchel L. Zoler Thomson Gale Thomson Gale |
Sale Price: $5.95
|
| Rosuvastatin helps lipids in metabolic syndrome.(News): An article from: Internal Medicine News Bruce Jancin International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| AstraZeneca calls Public Citizen's drive to remove rosuvastatin 'meritless'.(News)(Public Citizen Health Research Group): An article from: Internal Medicine News Elizabeth Mechcatie International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Rosuvastatin fares best in comparative statin efficacy trial: non-HDL-cholesterol-lowering results.(Clinical Rounds)(High density lipoprotein): An article from: Family Practice News Bruce Jancin International Medical News Group International Medical News Group |
Sale Price: $5.95
|

Not Signed In - 

